GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hangzhou AGS Medtech Co Ltd (SHSE:688581) » Definitions » Gross Profit

Hangzhou AGS Medtech Co (SHSE:688581) Gross Profit : ¥469.9 Mil (TTM As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Hangzhou AGS Medtech Co Gross Profit?

Hangzhou AGS Medtech Co's gross profit for the three months ended in Mar. 2025 was ¥90.9 Mil. Hangzhou AGS Medtech Co's gross profit for the trailing twelve months (TTM) ended in Mar. 2025 was ¥469.9 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Hangzhou AGS Medtech Co's gross profit for the three months ended in Mar. 2025 was ¥90.9 Mil. Hangzhou AGS Medtech Co's Revenue for the three months ended in Mar. 2025 was ¥128.6 Mil. Therefore, Hangzhou AGS Medtech Co's Gross Margin % for the quarter that ended in Mar. 2025 was 70.68%.

Hangzhou AGS Medtech Co had a gross margin of 70.68% for the quarter that ended in Mar. 2025 => Durable competitive advantage

During the past 8 years, the highest Gross Margin % of Hangzhou AGS Medtech Co was 72.11%. The lowest was 58.65%. And the median was 62.08%.


Hangzhou AGS Medtech Co Gross Profit Historical Data

The historical data trend for Hangzhou AGS Medtech Co's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou AGS Medtech Co Gross Profit Chart

Hangzhou AGS Medtech Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross Profit
Get a 7-Day Free Trial 104.48 305.47 252.79 360.54 459.08

Hangzhou AGS Medtech Co Quarterly Data
Dec17 Dec18 Dec19 Jun20 Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 80.08 108.83 119.28 150.89 90.90

Competitive Comparison of Hangzhou AGS Medtech Co's Gross Profit

For the Medical Devices subindustry, Hangzhou AGS Medtech Co's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hangzhou AGS Medtech Co's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hangzhou AGS Medtech Co's Gross Profit distribution charts can be found below:

* The bar in red indicates where Hangzhou AGS Medtech Co's Gross Profit falls into.


;
;

Hangzhou AGS Medtech Co Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Hangzhou AGS Medtech Co's Gross Profit for the fiscal year that ended in Dec. 2024 is calculated as

Gross Profit (A: Dec. 2024 )=Revenue - Cost of Goods Sold
=636.634 - 177.558
=459.1

Hangzhou AGS Medtech Co's Gross Profit for the quarter that ended in Mar. 2025 is calculated as

Gross Profit (Q: Mar. 2025 )=Revenue - Cost of Goods Sold
=128.6 - 37.704
=90.9

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥469.9 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Hangzhou AGS Medtech Co's Gross Margin % for the quarter that ended in Mar. 2025 is calculated as

Gross Margin % (Q: Mar. 2025 )=Gross Profit (Q: Mar. 2025 ) / Revenue (Q: Mar. 2025 )
=(Revenue - Cost of Goods Sold) / Revenue
=90.9 / 128.6
=70.68 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Hangzhou AGS Medtech Co  (SHSE:688581) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Hangzhou AGS Medtech Co had a gross margin of 70.68% for the quarter that ended in Mar. 2025 => Durable competitive advantage


Hangzhou AGS Medtech Co Gross Profit Related Terms

Thank you for viewing the detailed overview of Hangzhou AGS Medtech Co's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Hangzhou AGS Medtech Co Business Description

Traded in Other Exchanges
N/A
Address
No. 6 Kangxin Road, Building 597, Building 5, Yuhang District, Zhejiang Province, Hangzhou, CHN, 311106
Hangzhou AGS Medtech Co Ltd is engaged in Research & Development, production, and sales of endoscopic minimally invasive diagnosis and treatment devices. The company upholds the core values of create, insist, share, and providing patients and clinicians with safer and more efficient minimally invasive endoscopic devices, helping patients reduce pain and medical costs.
Executives
Chen Jun Can senior management
Li Peng Core technical personnel
Han Chun Qi Directors, senior managers, core technical personnel
Sheng Yue Yuan Director
Zhang Qin Hua senior management
Zhang Cheng Director

Hangzhou AGS Medtech Co Headlines

No Headlines